Sarepta Therapeutics, Inc. (SRPT) Social Stream
SAREPTA THERAPEUTICS INC (SRPT) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering SAREPTA THERAPEUTICS INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-08 | 17 | $160 | $90 | $127.25 | $97.34 | 30.73% |
| 2021-12-26 | 16 | $160 | $90 | $127.076 | $97.34 | 30.55% |
| 2022-01-05 | 16 | $160 | $90 | $126.538 | $97.34 | 30% |
| 2022-01-11 | 13 | $160 | $90 | $128.083 | $97.34 | 31.58% |
| 2022-01-19 | 14 | $160 | $92 | $128.25 | $97.34 | 31.75% |
| 2022-01-26 | 14 | $160 | $92 | $126.833 | $97.34 | 30.3% |
| 2022-02-09 | 14 | $160 | $71 | $125.083 | $97.34 | 28.5% |
| 2022-03-04 | 13 | $150 | $71 | $121.909 | $97.34 | 25.24% |
| 2022-03-07 | 13 | $150 | $80 | $122.727 | $97.34 | 26.08% |
| 2022-03-16 | 13 | $150 | $80 | $123 | $97.34 | 26.36% |
| 2022-04-04 | 13 | $150 | $80 | $124.3 | $97.34 | 27.7% |
| 2022-04-12 | 13 | $150 | $77 | $124 | $97.34 | 27.39% |
| 2022-04-20 | 13 | $150 | $77 | $124.2 | $97.34 | 27.59% |
| 2022-05-09 | 13 | $150 | $77 | $124.1 | $97.34 | 27.49% |
| 2022-05-13 | 13 | $150 | $77 | $124.6 | $97.34 | 28% |
| 2022-05-18 | 13 | $150 | $74 | $124.3 | $97.34 | 27.7% |
| 2022-05-24 | 14 | $155 | $74 | $127.09 | $97.34 | 30.56% |
| 2022-06-22 | 13 | $155 | $74 | $127.09 | $97.34 | 30.56% |
| 2022-07-25 | 13 | $155 | $80 | $126.272 | $97.34 | 29.72% |
| 2022-07-29 | 13 | $162 | $80 | $127.363 | $97.34 | 30.84% |
| 2022-08-03 | 13 | $162 | $80 | $127.583 | $97.34 | 31.07% |
| 2022-08-04 | 13 | $162 | $100 | $132.076 | $97.34 | 35.69% |
| 2022-08-09 | 13 | $182 | $100 | $133.769 | $97.34 | 37.42% |
| 2022-08-13 | 13 | $182 | $100 | $134.923 | $97.34 | 38.61% |
| 2022-09-06 | 13 | $182 | $100 | $136.461 | $97.34 | 40.19% |
| 2022-09-07 | 13 | $182 | $100 | $137.461 | $97.34 | 41.22% |
| 2022-09-14 | 13 | $182 | $114 | $140.153 | $97.34 | 43.98% |
| 2022-10-03 | 12 | $182 | $114 | $140.153 | $97.34 | 43.98% |
| 2022-10-12 | 12 | $182 | $114 | $141.916 | $97.34 | 45.79% |
| 2022-10-20 | 12 | $182 | $114 | $143.5 | $97.34 | 47.42% |
| 2022-10-21 | 12 | $182 | $114 | $144 | $97.34 | 47.94% |
| 2022-11-25 | 12 | $190 | $114 | $146.153 | $97.34 | 50.15% |
| 2022-12-02 | 12 | $190 | $114 | $146.846 | $97.34 | 50.86% |
| 2022-12-19 | 13 | $190 | $114 | $147.642 | $97.34 | 51.68% |
| 2022-12-22 | 14 | $190 | $114 | $148.466 | $97.34 | 52.52% |
| 2022-12-29 | 14 | $190 | $114 | $150.066 | $97.34 | 54.17% |
| 2023-01-04 | 15 | $190 | $114 | $151.533 | $97.34 | 55.67% |
| 2023-01-10 | 15 | $190 | $114 | $151.666 | $97.34 | 55.81% |
| 2023-01-16 | 15 | $190 | $122 | $152.4 | $97.34 | 56.56% |
| 2023-02-27 | 15 | $190 | $122 | $153.4 | $97.34 | 57.59% |
| 2023-03-01 | 16 | $190 | $122 | $154.933 | $97.34 | 59.17% |
| 2023-03-02 | 16 | $226 | $122 | $169 | $97.34 | 73.62% |
| 2023-03-09 | 16 | $226 | $122 | $172.533 | $97.34 | 77.25% |
| 2023-03-17 | 16 | $226 | $122 | $171.666 | $97.34 | 76.36% |
| 2023-03-21 | 16 | $226 | $122 | $171.333 | $97.34 | 76.01% |
| 2023-03-22 | 17 | $226 | $122 | $174.666 | $97.34 | 79.44% |
| 2023-04-05 | 18 | $226 | $122 | $174.058 | $97.34 | 78.81% |
| 2023-04-24 | 18 | $226 | $122 | $173.823 | $97.34 | 78.57% |
| 2023-05-03 | 19 | $226 | $122 | $174.444 | $97.34 | 79.21% |
| 2023-05-04 | 19 | $206 | $122 | $170.222 | $97.34 | 74.87% |
| 2023-05-10 | 19 | $206 | $122 | $171.5 | $97.34 | 76.19% |
| 2023-05-15 | 19 | $206 | $122 | $173 | $97.34 | 77.73% |
| 2023-05-24 | 19 | $218 | $122 | $177 | $97.34 | 81.84% |
| 2023-05-25 | 19 | $218 | $122 | $176.722 | $97.34 | 81.55% |
| 2023-06-06 | 20 | $218 | $122 | $175.368 | $97.34 | 80.16% |
| 2023-06-23 | 20 | $218 | $122 | $175.421 | $97.34 | 80.21% |
| 2023-07-28 | 20 | $218 | $122 | $181.263 | $97.34 | 86.22% |
| 2023-08-04 | 20 | $218 | $139 | $184.555 | $97.34 | 89.6% |
| 2023-09-13 | 18 | $223 | $139 | $186.647 | $97.34 | 91.75% |
| 2023-10-17 | 19 | $223 | $139 | $186.647 | $97.34 | 91.75% |
| 2023-10-25 | 19 | $223 | $139 | $186.176 | $97.34 | 91.26% |
| 2023-11-01 | 19 | $223 | $40 | $167.875 | $97.34 | 72.46% |
| 2023-11-03 | 20 | $215 | $80 | $146.5 | $97.34 | 50.5% |
| 2023-11-09 | 20 | $215 | $80 | $146.312 | $97.34 | 50.31% |
| 2023-11-21 | 20 | $224 | $80 | $150.882 | $97.34 | 55.01% |
| 2023-12-13 | 20 | $224 | $80 | $145.294 | $97.34 | 49.26% |
| 2023-12-29 | 20 | $224 | $80 | $141.058 | $97.34 | 44.91% |
The Trend in the Analyst Price Target
SRPT's average price target has moved down $29.16 over the prior 34 weeks.
Over the past 50 weeks, SRPT's average upside potential has been 48.89%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-01-16 | 14 | 190 | 122 | 153.400 | 126.70 | 21.07% |
| 2023-02-27 | 15 | 190 | 122 | 153.400 | 118.13 | 29.86% |
| 2023-04-24 | 18 | 226 | 122 | 173.823 | 126.68 | 37.21% |
| 2023-08-04 | 20 | 218 | 139 | 185.000 | 105.31 | 75.67% |
| 2023-12-13 | 20 | 224 | 80 | 145.294 | 92.11 | 57.74% |
SRPT Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.5 | 14 | 2 | 4 | 0 | 0 | 20 |
The Trend in the Broker Recommendations
Over the past 17 months, SRPT's average broker recommendation rating worsened by 0.04.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- SAREPTA THERAPEUTICS INC's average analyst price target is greater than 7088.94% of all US stocks.
- To contextualize these metrics, consider that out of Pharmaceutical Products stocks, SAREPTA THERAPEUTICS INC's number of analysts covering the stock is greater than 7511.93% of them.
- SAREPTA THERAPEUTICS INC's upside potential (average analyst target price relative to current price) is higher than 6786.14% of stocks in the large market cap category.
- SAREPTA THERAPEUTICS INC's variance in analysts' estimates is lower than -5638.86% of stocks in the large market cap category.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to SAREPTA THERAPEUTICS INC are MRVI, ABCL, and BLUE.
View All Top Stocks by Price Target
Is SRPT a Buy, Hold or Sell? See the POWR Ratings now!